These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

619 related articles for article (PubMed ID: 8173995)

  • 1. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
    Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
    Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of anti-A and anti-B isohemagglutinins in cord blood of ABO incompatible newborn infants: correlation with hyperbilirubinemia.
    Serrao PA; Modanlou HD
    J Perinatol; 1989 Jun; 9(2):154-8. PubMed ID: 2738726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Morbidity of ABO haemolytic disease in the newborn.
    Bhat YR; Kumar CG
    Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does prophylactic phototherapy prevent hyperbilirubinemia in neonates with ABO incompatibility and positive Coombs' test?
    Yaseen H; Khalaf M; Rashid N; Darwich M
    J Perinatol; 2005 Sep; 25(9):590-4. PubMed ID: 16034477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum and outcome analysis of marked neonatal hyperbilirubinemia with blood group incompatibility.
    Weng YH; Chiu YW
    Chang Gung Med J; 2009; 32(4):400-8. PubMed ID: 19664346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Positive Direct Antiglobulin Test: Is It a Risk Factor for Significant Hyperbilirubinemia in Neonates with ABO Incompatibility?
    Ercin S; Coskun Y; Kayas K; Kavas N; Gursoy T
    Am J Perinatol; 2024 Mar; 41(4):505-510. PubMed ID: 34847590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal IgG anti-A and anti-B titres predict outcome in ABO-incompatibility in the neonate.
    Bakkeheim E; Bergerud U; Schmidt-Melbye AC; Akkök CA; Liestøl K; Fugelseth D; Lindemann R
    Acta Paediatr; 2009 Dec; 98(12):1896-901. PubMed ID: 19703120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Value of the Coombs test in ABO incompatibility].
    Bel Comos J; Ribera Crusafont A; Natal Pujol A; Coroleu Lletget W; Pujol Posch N; Prats Viñas J
    An Esp Pediatr; 1991 Oct; 35(4):248-50. PubMed ID: 1763851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
    Akgül S; Korkmaz A; Yiğit S; Yurdakök M
    Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn.
    Miqdad AM; Abdelbasit OB; Shaheed MM; Seidahmed MZ; Abomelha AM; Arcala OP
    J Matern Fetal Neonatal Med; 2004 Sep; 16(3):163-6. PubMed ID: 15590442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
    Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
    Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Positive Coomb's test in newborns; causes and clinical consequences Summary of cases diagnosed in the Blood Bank in the years 2005 to 2012].
    Kristinsdottir T; Kjartansson S; Hardardottir H; Jonsson T; Halldorsdottir AM
    Laeknabladid; 2016 Jul; 102(7-8):326-31. PubMed ID: 27531851
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Revisiting ABO incompatibility as a risk factor for significant neonatal hyperbilirubinemia.
    Khurana R; Batra P; Faridi M; Khan N
    Trop Doct; 2019 Jul; 49(3):201-204. PubMed ID: 30943888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct antiglobulin test in the prediction of hyperbilirubinemia and predischarge bilirubin levels in infants with mother-infant blood type incompatibility.
    Mehta R; Petrova A
    Pediatr Neonatol; 2021 Jul; 62(4):406-411. PubMed ID: 33967007
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ABO system incompatibility: relationship between direct Coombs test positivity and neonatal jaundice.
    Orzalesi M; Gloria F; Lucarelli P; Bottini E
    Pediatrics; 1973 Feb; 51(2):288-9. PubMed ID: 4633082
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prevalence of immunohematologic tests at birth and the incidence of hemolytic disease in the newborn].
    Cianciarullo MA; Ceccon ME; Vaz Fv
    Rev Assoc Med Bras (1992); 2003; 49(1):45-53. PubMed ID: 12724812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of neonatal hyperbilirubinemia in babies born to 'O' positive mothers: a prospective cohort study.
    Kalakheti BK; Singh R; Bhatta NK; Karki A; Baral N
    Kathmandu Univ Med J (KUMJ); 2009; 7(25):11-5. PubMed ID: 19483446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Incidence, laboratory diagnosis and serologic prediction of hemolytic disease of newborn infants due to ABO incompatibility].
    Schönitzer D; Frisch H
    Padiatr Padol; 1984; 19(3):263-78. PubMed ID: 6472867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.